Home LiteratureArticle Details
PMID: 18435704 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.

Pigment cell & melanoma research ·Vol. 21 ·No. 3 ·2008-06-00 ·Pages 368-78

Shin SS, Namkoong J, Wall BA, Gleason R, Lee HJ, Chen S

Abstract

Previously, we reported a transgenic mouse line, TG-3, that develops spontaneous melanoma with 100% penetrance. We demonstrated that ectopic expression of Grm1 in melanocytes was sufficient to induce melanoma in vivo. In this present study, the transforming properties of Grm1 in two cultured immortalized melanocytes were investigated. We showed that, in contrast to parental melanocytes, these Grm1-clones have lost their requirement of TPA supplement for proliferation and have acquired the ability to form colonies in semi-solid medium. Xenografts of these cells formed robust tumors in both immunodeficient nude and syngeneic mice with a short latency (3-5 days). The malignancy of these cells was demonstrated by angiogenesis and invasion to the muscle and the intestine. The requirement of Grm1 expression for the maintenance of transformation was demonstrated by an inducible siRNA system. Induction of expression of siRNA for Grm1 reduced the number of proliferating/viable cells in vitro and suppressed in vivo xenografted tumor growth in comparison with control. Taken together, these results showed that expression of exogeneously introduced Grm1 is sufficient to induce full transformation of immortalized melanocytes.

MeSH Terms
Animals Cell Line, Tumor Cell Transformation, Neoplastic/genetics Gene Expression Regulation, Neoplastic/drug effects Melanocytes/drug effects,physiology Melanoma/drug therapy,genetics,metabolism Mice Mice, Nude Oncogenes/drug effects,genetics,physiology RNA, Small Interfering/pharmacology Receptors, Metabotropic Glutamate/genetics,physiology Xenograft Model Antitumor Assays
Chemicals
RNA, Small Interfering Receptors, Metabotropic Glutamate metabotropic glutamate receptor type 1
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Shin Seung-Shick
Department of Chemical Biology, Ernest Mario School of Pharmacy, Susan Lehman Cullman Laboratory for Cancer Research, Rutgers University, Piscataway, NJ, USA.
Namkoong Jin
Wall Brian A
Gleason Ryan
Lee Hwa Jin
Chen Suzie
References (38)
38 references, click to expand
  1. V599EB-RAF is an oncogene in melanocytes.
    Cancer Res. 2004 Apr 1;64(7):2338-42 PMID: 15059882
  2. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
    Cell Signal. 2006 Aug;18(8):1279-86 PMID: 16305822
  3. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins.
    Int J Cancer. 1997 Sep 26;73(1):94-103 PMID: 9334815
  4. The regulation of normal melanocyte proliferation.
    Pigment Cell Res. 2000 Feb;13(1):4-14 PMID: 10761990
  5. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.
    J Invest Dermatol. 2001 Dec;117(6):1483-9 PMID: 11886512
  6. BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.
    Mol Pharmacol. 2001 May;59(5):965-73 PMID: 11306677
  7. Cloning of novel splice variants of mouse mGluR1.
    Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):93-103 PMID: 10581402
  8. Progressive appearance of pigmentation in amelanotic melanoma lesions.
    Pigment Cell Res. 2002 Aug;15(4):282-9 PMID: 12100494
  9. Establishment of conditional vectors for hairpin siRNA knockdowns.
    Nucleic Acids Res. 2003 Aug 1;31(15):e77 PMID: 12888529
  10. The metabotropic glutamate receptors: structure and functions.
    Neuropharmacology. 1995 Jan;34(1):1-26 PMID: 7623957
  11. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.
    Biochem J. 2001 Nov 1;359(Pt 3):465-84 PMID: 11672421
  12. Molecular determinants of metabotropic glutamate receptor signaling.
    Trends Pharmacol Sci. 2001 Mar;22(3):114-20 PMID: 11239574
  13. Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes.
    J Cell Physiol. 2000 Jun;183(3):364-72 PMID: 10797311
  14. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
    Cancer Res. 2007 Mar 1;67(5):2298-305 PMID: 17332361
  15. One-week 96-well soft agar growth assay for cancer target validation.
    Biotechniques. 2004 May;36(5):826-8, 830, 832-3 PMID: 15152603
  16. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.
    Nat Genet. 2005 Oct;37(10):1047-54 PMID: 16142232
  17. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.
    Cancer Res. 2003 Feb 15;63(4):756-9 PMID: 12591721
  18. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.
    Proc Natl Acad Sci U S A. 1975 Nov;72(11):4435-9 PMID: 172908
  19. Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling.
    J Biol Chem. 2003 Mar 14;278(11):9790-5 PMID: 12514183
  20. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.
    Oncogene. 2000 Sep 21;19(40):4647-59 PMID: 11030154
  21. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth.
    Int J Cancer. 1987 Mar 15;39(3):414-8 PMID: 3102392
  22. Development of heritable melanoma in transgenic mice.
    J Invest Dermatol. 1998 Mar;110(3):247-52 PMID: 9506443
  23. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
    Nat Genet. 2003 May;34(1):108-12 PMID: 12704387
  24. Mutations of the BRAF gene in human cancer.
    Nature. 2002 Jun 27;417(6892):949-54 PMID: 12068308
  25. Glutamate antagonists limit tumor growth.
    Proc Natl Acad Sci U S A. 2001 May 22;98(11):6372-7 PMID: 11331750
  26. The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma.
    Oncol Rep. 2007 Jun;17(6):1399-404 PMID: 17487397
  27. Activated ras. Yet another player in melanoma?
    Am J Pathol. 1996 Sep;149(3):739-44 PMID: 8780377
  28. p16(Ink4a) in melanocyte senescence and differentiation.
    J Natl Cancer Inst. 2002 Mar 20;94(6):446-54 PMID: 11904317
  29. Glutamate signalling in non-neuronal tissues.
    Trends Pharmacol Sci. 2001 Apr;22(4):174-81 PMID: 11282417
  30. Glutamate signaling in peripheral tissues.
    Eur J Biochem. 2004 Jan;271(1):1-13 PMID: 14686914
  31. Genetic analysis of the GRM1 gene in human melanoma susceptibility.
    Eur J Hum Genet. 2007 Nov;15(11):1176-82 PMID: 17609672
  32. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.
    EMBO J. 2000 Jun 15;19(12):2900-10 PMID: 10856235
  33. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  34. Differential oncogenic potential of activated RAS isoforms in melanocytes.
    Oncogene. 2007 Jul 5;26(31):4563-70 PMID: 17297468
  35. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth.
    Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15605-10 PMID: 16230611
  36. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.
    J Cell Biol. 1989 Dec;109(6 Pt 1):3115-28 PMID: 2556408
  37. Glutamate receptors on human melanocytes regulate the expression of MiTF.
    Pigment Cell Res. 2006 Feb;19(1):58-67 PMID: 16420247
  38. Glutamate release promotes growth of malignant gliomas.
    Nat Med. 2001 Sep;7(9):1010-5 PMID: 11533703
Article Info
Journal
Pigment cell & melanoma research
Abbr.
Pigment Cell Melanoma Res
ISSN
1755-1471
Published
2008-06-00
Epub
2008-00-23
Pages
368-78
Language
English
Region
England
NLM ID
101318927
PMCID
PMC2854004
Subset
IM
Grants
NIGMS NIH HHS · R25 GM055145 · United States
NCI NIH HHS · R01 CA108720-04 · United States
NIGMS NIH HHS · GM55145 · United States
NCI NIH HHS · R01 CA108720-05 · United States
NIEHS NIH HHS · ES05022 · United States
NCI NIH HHS · R01 CA108720 · United States
NCI NIH HHS · R01CA108720 · United States
NIEHS NIH HHS · P30 ES005022 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com